MedTrace Logo

An Exercise Facilitator to Activate Simple Training Programs in the Dialysis Center

NCT04282616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2025-08-11

No results posted yet for this study

Summary

Low physical activity levels and progressive poor functional capacity affect quality of life and clinical outcomes of Chronic Kidney Disease (CKD) patients. Interventions to prevent the functional decline associated with a sedentary lifestyle or to relief from deconditioning are crucial, considering the significant beneficial effects of exercise in all CKD patients, especially in End-stage Kidney Disease patients (ESKD). Unfortunately, physical and psychological barriers to exercise are present and physical activity management is not routinely addressed in the patient's care.

For the first time the project aims to test the impact of the regular presence of an exercise specialist in the Nephrology Unit.

This facilitator, evaluating capacity, motivation and preferences of each patient, will design tailored solutions and assess the related outcomes. Several design of training programs will be proposed to dialysis patients, that can choose the exercise option that best fits their needing.

The study will determine the feasibility of the project, the patients' adherence and the effectiveness of the programs proposed to improve the patients' lifestyle.

Conditions

  • Chronic Kidney Disease Stage 5 on Dialysis

Interventions

OTHER

Home-based unstructured physical activity program

Counselling on physical activity according to American College of Sports Medicine guidelines

OTHER

Home-based structured low-intensity physical activity program

Structured home-based low-intensity intermittent walking program

OTHER

In-hospital structured supervised physical activity program

Supervised exercise training program

Sponsors & Collaborators

  • Università degli Studi di Ferrara

    collaborator OTHER

  • University Hospital of Ferrara

    lead OTHER

Principal Investigators

  • Fabio Manfredini, MD · University of Ferrara and University Hospital of Ferrara

  • Alda Storari, MD · University Hospital of Ferrara

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-26
Primary Completion
2024-12-31
Completion
2025-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04282616 on ClinicalTrials.gov